FDA allows emergency use of anti-viral vaccine Remdesivir to treat Covid-19 patients

The food and drug administration (FDA) gave emergency use authorisation (EUA) for the use of investigational anti-viral Remdesivir in the treatment of Covid-19 patients. The FDA authorisation came after researches reported Remdesivir shortened the recovery times in people affected by Covid-19.